Paul McCreadie - Profile and Investment Details

Investor Profile

Paul McCreadie is a Venture Capital, Private Equity Firm based in Ann Arbor, Michigan, United States with a diverse investment portfolio that includes companies such as Inogen, Cardiac Dimensions, Aira, Strata Oncology, Esperion Therapeutics, Concerto Healthcare, Tangent Medical Technologies, Asterand, Rethink First, SI-BONE, Koya Medical, Jumpcode Genomics, NxThera, Accuri Cytometers, HandyLab, Swift Biosciences, Advance Medical, Mirabilis Medical, NeuMoDx Molecular, Fifth Eye, Wellfount, Flosonics, nVision Medical, Fidelis SeniorCare, Pear Therapeutics, Health Scholars, SonarMD, EQRx, Delphinus Medical Technologies, Uptake Medical, BAROnova, ArborMetrix, Francis Medical, CardioMEMS, KFx Medical, My Health Direct, Sonitus Medical, Intellicyt, Ebb Therapeutics, BioIQ, Cervilenz, NeoGuide Systems, PathCentral, Adavium, Hicuity Health, Inc., Lucina Health. Over time, Paul McCreadie has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Paul McCreadie is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Wellness, Women Founded, Women Led, Biotech, Analytics, Medical Device, Software, Healthcare, Biotechnology, Internet, Medical, SaaS, Therapeutics, mHealth, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Paul McCreadie, as their portfolio suggests a familiarity and interest in this area.

Understanding Paul McCreadie’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.